Documentation scienceplus.abes.fr version Bêta

À propos de : Testosterone patches for female sexual dysfunction        

AttributsValeurs
type
Is Part Of
Subject
Title
  • Testosterone patches for female sexual dysfunction
has manifestation of work
Abstract
  • There is some suggestion of a link between sexual dysfunction in postmenopausal women and low circulating concentrations of testosterone.1 This underlies the development of a new transdermal testosterone patch (▼ Intrinsa - Procter & Gamble) that has recently been licensed in the UK for the treatment of women who have hypoactive sexual desire disorder (HSDD) following a menopause induced by surgery (i.e. bilateral salpingooophorectomy and hysterectomy) and who are receiving concomitant oestrogen replacement therapy.2 Here we discuss the diagnosis of HSDD, as well as the evidence for using transdermal testosterone patches in women in whom this diagnosis is made.
article type
publisher identifier
  • dt0930
is part of this journal
PubMed ID
  • 19261838



Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata